L-372662 | m-entrepreneurship.com

Product Name :
L-372662

Search keywords :
L-372662

drugId :
null

Target Vo:
Oxytocin receptor

Target Vo Short Name :
OT-R

Moa_Name:
Oxytocin receptor antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Merck & Co

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Premature Birth

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Adecatumumab web
Cyclin B1 Rabbit mAb Autophagy
Glycogen synthase Antibody: Glycogen synthase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to Glycogen synthase. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts